BRPI0415616A - uso do xenÈnio para a prevenção da morte programada da célula - Google Patents

uso do xenÈnio para a prevenção da morte programada da célula

Info

Publication number
BRPI0415616A
BRPI0415616A BRPI0415616-1A BRPI0415616A BRPI0415616A BR PI0415616 A BRPI0415616 A BR PI0415616A BR PI0415616 A BRPI0415616 A BR PI0415616A BR PI0415616 A BRPI0415616 A BR PI0415616A
Authority
BR
Brazil
Prior art keywords
cell death
xenon
prevent
programmed cell
prevent programmed
Prior art date
Application number
BRPI0415616-1A
Other languages
English (en)
Inventor
Christian Peter Petzelt
Wolfgang Johannes Kox
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab filed Critical Aga Ab
Publication of BRPI0415616A publication Critical patent/BRPI0415616A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"USO DO XENÈNIO PARA A PREVENçãO DA MORTE PROGRAMADA DA CéLULA". é descrito o uso do xenónio para prevenir ou reduzir a morte celular, preferivelmente, a apoptose aberrante. As modalidades preferidas referem-se ao uso do xenónio para prevenir (a) os danos celulares para tecidos e órgãos a ser transplantados, (b) a morte apoptótica da célula após a cirurgia a laser do olho, e (c) para proteger células endoteliais do intestino na sépsis.
BRPI0415616-1A 2003-10-21 2004-10-13 uso do xenÈnio para a prevenção da morte programada da célula BRPI0415616A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03024201 2003-10-21
PCT/EP2004/011504 WO2005039600A2 (en) 2003-10-21 2004-10-13 Use of xenon for the prevention of programmed cell death

Publications (1)

Publication Number Publication Date
BRPI0415616A true BRPI0415616A (pt) 2006-12-12

Family

ID=34384596

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415616-1A BRPI0415616A (pt) 2003-10-21 2004-10-13 uso do xenÈnio para a prevenção da morte programada da célula

Country Status (7)

Country Link
US (1) US20080031971A1 (pt)
EP (1) EP1675597A2 (pt)
JP (1) JP2007509091A (pt)
AU (1) AU2004283448B2 (pt)
BR (1) BRPI0415616A (pt)
CA (1) CA2542412A1 (pt)
WO (1) WO2005039600A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0520176D0 (en) * 2005-10-04 2005-11-09 Imp College Innovations Ltd Use
US8158339B2 (en) 2008-07-07 2012-04-17 Rich Products Corporation Method of preserving a platelet concentrate under elevated xenon concentration and pressure with refrigeration
WO2010005968A1 (en) * 2008-07-07 2010-01-14 Rich Products Corporation Method for storage of live crustaceans
CA2824948C (en) * 2011-02-07 2020-06-02 Rich Products Corporation Method for preserving cells and cell cultures
CN104114688B (zh) 2011-09-26 2016-08-31 先进保存技术股份有限公司 活组织保存的方法
FR2996459B1 (fr) * 2012-10-09 2015-02-06 Air Liquide Utilisation d'un melange argon/xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996458B1 (fr) * 2012-10-09 2015-02-27 Air Liquide Utilisation de xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996457B1 (fr) * 2012-10-09 2019-11-29 L'air Liquide,Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Utilisation d'argon pour prevenir ou traiter les consequences neurologiques d'un choc septique
JP2014201580A (ja) * 2013-04-10 2014-10-27 株式会社昭和冷凍プラント 窒素水を用いた移植臓器の保存用又は洗浄用の処理液及びその調製方法
FR3004350A1 (fr) * 2013-04-12 2014-10-17 Air Liquide Delivrance de gaz medical a un receveur de materiel biologique
FR3004312A1 (fr) * 2013-04-12 2014-10-17 Air Liquide Delivrance de gaz medical a un donneur avant un prelevement de materiel biologique
RU2758536C1 (ru) * 2020-12-17 2021-10-29 Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Способ снижения воспалительной гиперактивации нейтрофилов

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838061A1 (de) * 1988-11-10 1990-05-23 Holzer Walter Sterile selbstklebefolie fuer die medizinische eingriffsvorbereitung
WO1991006650A1 (en) * 1989-10-27 1991-05-16 Cetus Corporation C1 inhibitor muteins and uses thereof
JPH04197169A (ja) * 1990-11-29 1992-07-16 Wadley Technol Inc 微生物分析のための試料の安定化
US5228434A (en) * 1991-07-16 1993-07-20 Praxair Technology, Inc. Mixture for anesthesia
CA2272578A1 (en) * 1996-11-18 1998-05-28 Mcgill University Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
AR016551A1 (es) * 1997-07-30 2001-07-25 Smithkline Beecham Corp Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos
JPH11158158A (ja) * 1997-12-03 1999-06-15 Snow Brand Milk Prod Co Ltd 新規ベンゾイミダゾール誘導体
DE19910986C2 (de) * 1999-03-11 2001-06-07 Aga Ab Verwendung von Xenon bei der Behandlung von Neurointoxikationen
GB9913677D0 (en) * 1999-06-11 1999-08-11 Imperial College Formulation
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
FR2812197B1 (fr) * 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
US6475716B1 (en) * 2001-03-06 2002-11-05 Biobank Co., Ltd. Method for preserving mammalian organs
GB0209998D0 (en) * 2002-05-01 2002-06-12 Protexeon Ltd Use

Also Published As

Publication number Publication date
WO2005039600A2 (en) 2005-05-06
JP2007509091A (ja) 2007-04-12
AU2004283448B2 (en) 2009-02-19
EP1675597A2 (en) 2006-07-05
US20080031971A1 (en) 2008-02-07
AU2004283448A1 (en) 2005-05-06
CA2542412A1 (en) 2005-05-06
WO2005039600A3 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
BRPI0415616A (pt) uso do xenÈnio para a prevenção da morte programada da célula
BR9805921A (pt) Enxertos feitos de membrana amniótica; processos de separação, conservação e uso desses enxertos em cirúrgias
CL2010000606A1 (es) Uso de derivados de eritropoyetina en la preparacion de un medicamento util para proteger, mantener, mejorar o recuperar la viabilidad de celulas que responden a eritropoyetina en condiciones anomalas que afectan las celulas, tejidos u organos asociados; derivados de eritropoyetinas y composicion que las comprende (divisional de la solicitud 3188-2001).
Sturdy et al. Surgical sponges: a cause of granuloma and adhesion formation
Sheridan et al. Management of burn wounds with prompt excision and immediate closure
BR0015194A (pt) Uso de um inibidor de egfr-tirosina-quinase, e, métodos para redução da transformação de células epiteliais e para causar reversão substancial de tecido epitelial
Breadon et al. Autografts of uncrushed and crushed bone and cartilage: experimental observations and clinical implications
Zhang et al. Studies on membrane permeability of zebrafish (Danio rerio) oocytes in the presence of different cryoprotectants
BRPI0600855A (pt) dispositivo para drenagem de humor aquoso em casos de glaucoma
AR018719A1 (es) Inhibidores de renina.
DK1140016T3 (da) Præparat og kit til anvendelse ved intraoculær kirurgi
CR8207A (es) Un conjugado citotoxico ca6 antigeno- especifico y metodos para utilizar el mismo
BR0009610A (pt) Inibidores de caspase e uso dos mesmos
WO2001076364A3 (en) Composition and methods for tissue preservation
ATE276743T1 (de) Gegen gefrier/auftau-schaden resistente liposomzusammensetzung
TR201900937T4 (tr) Organların ve dokuların muhafaza edilmesine yönelik yöntem.
NO20020938L (no) Substituerte alfa-hydroksysyre-caspaseinhibitorer og deres anvendelse
IT1305306B1 (it) Uso della pirenoxina per la protezione dei tessuti corneali ininterventi di fotocheratectomia.
FR2793651B1 (fr) Solution aqueuse de conservation de tissus et d'organes
BR0113062A (pt) Derivados de heterociclilalquilazol e seu emprego como agente para o combate de parasitas
Harvig et al. Effects of cold ischemia on the preserved and transplanted rat kidney: structural changes of the loop of Henle, distal tubule and collecting duct
AR037794A1 (es) Combinaciones de agentes viscoelasticos para el uso durante la cirugia
PE92298A1 (es) Variantes de aprotinina con propiedades mejoradas
AR033965A1 (es) Uso de un antagonista de tnfalfa, para tratar o inhibir la lesion celular o la muerte de las celulas
Lundblad et al. Spermatic cord malignancies

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: IMPERIAL INNOVATIONS LIMITED (GB)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL